Table 3.
Compound Number | Compound Structure | IC50 | Producer |
---|---|---|---|
10 | EC50 for EPO 1–20 nM | GSK | |
11 | N/A | Amgen | |
12 | 0.7 nM | Merck | |
13 | 70 nM | Bayer | |
14 | 2 μM | Cornell University | |
15 | 10 μM | Cornell University | |
16 | 4 nM | Merck | |
17 | 0.2 nM | Merck |
Compound Number | Compound Structure | IC50 | Producer |
---|---|---|---|
10 | EC50 for EPO 1–20 nM | GSK | |
11 | N/A | Amgen | |
12 | 0.7 nM | Merck | |
13 | 70 nM | Bayer | |
14 | 2 μM | Cornell University | |
15 | 10 μM | Cornell University | |
16 | 4 nM | Merck | |
17 | 0.2 nM | Merck |